2019第四届亚太医疗政策峰会 产业会议
会议标题 2019第四届亚太医疗政策峰会
会议时间 2019-05-10 到 2019-05-11
会议地点 新加坡
官方网址

4th Healthcare Policy Asia Pacific Summit 2019

2019第四届亚太医疗政策峰会


May 9-10, 2019 • Singapore


About 

关于


About this Event


Why attend HAP4? (event background)


The market for healthcare in the Asia Pacific region expanded at more than a 12% CAGR from 2012 to 2018, and strong growth is projected for the near future. With continued population growth, increased disposable incomes, and rapid urbanization, the Asia Pacific region is ripe with opportunity for global healthcare providers. However, as government policies and market conditions across the region differ substantially from those of the European and American markets, the continued development of the healthcare industry faces a set of unique challenges.


The 4th Asia Pacific Healthcare Summit 2019 will provide attendees with detailed information on the latest regulatory policies for healthcare across the Asia Pacific region, and offer a platform for healthcare industry professionals to share experiences, and express opinions on optimal business practices in the wake of changes within the industry.


What you will learn (highlights)

-More than 100 Delegates interpreting healthcare regulations in Singapore, Japan, South Korea, Thailand, India, Vietnam, and other major jurisdictions

-Firsthand testimony from government officials and industry leaders on healthcare policy in the APAC region and around the world, as well as future market trends

-Detailed look at the registration process and market access strategy for healthcare products.

-The latest knowledge on quality assurance and regulatory compliance for medical devices and pharmaceuticals

-In-depth analysis of product development and clinical trial requirements in the Asia Pacific region

-Information on cutting-edge innovationintegrating drugs with medical devices

-Challenges and opportunities for medical device supply chains and distributors

-Robust exchange between company representatives and government regulators, in the interest of developing the industry


Speakers   

演讲嘉宾


Speakers to Invite

Health Sciences Authority (HSA), Singapore

The Ministry of Food and Drug Safety (MFDS), Korea 

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

The Therapeutic Goods Administration (TGA), Australia

Food and Drug Administration (FDA), Thailand

Ministry of Health Vietnam

Ministry of Health Malaysia

Ministry of Health & Family Welfare (MOHFW), India 

World Health Organization (WHO)

The ASEAN Secretariat

Leading International Healthcare Companies


Attendees    

参会嘉宾


Who should attend?

By Industry 

• Pharmaceutical Companies

• Medical Device Companies

• Medical Merchandising

• Law Firm/Advisor Consulting

• Medical Services

• Insurance Companies

By Job Title

• Top Management

• Government Affairs Director/Manager

• Regulatory Affairs Director/Manager

• Registration Director/Manager

• Quality Assurance/ Compliance

• Medical Affairs Director/Manager

• Business & Marketing Director/Manager

• Public Relations Director/Manager

• External/Corporate Affairs Director/ Manager

• Legal Director/Manager


Some Previous Attendees 


3M Asia Pacific Pte Ltd.

Baxter International Inc.-Baxalta

Allergan Inc.

Aspen Pharmacare Holdings Limited

SANOFI PASTEUR

Astrazeneca

St. Jude Medical

Ipsen

Borouge

C. R. Bard

Bayer Healthcare

Fresenius Medical Care Asia- Pacific Ltd.

GSK (GlaxoSmithKline Pte Ltd)

Takeda Pharmaceutical Company Limited

Janssen Pharmaceuticals, Inc. Johnson & Johnson

Johnson & Johnson

Medtronic, Inc. 

Merck

MSD International

Sanofi

Mundipharma International

Philips

Linde Gas Asia Pte Ltd.

Novartis Asia Pacific Pharmaceuticals Pte Ltd.

Kimberly-Clark Health Care_ Halyard

Hologic, Inc.

Air Liquide (China) Holding Co., Ltd.

Cordis (Shanghai) Medical Devices Co., Ltd.

Shire Pharmaceuticals Group plc

Illumina

SchlafenderHase

SERVIER

Thermo Fisher Scientific Inc

Teva Pharmaceutical Industries Ltd.

Viveve

Baker & McKenzie

Beckman Coulter Danaher (Danaher Bernstein)

Biogen Idec

B. Braun Medical Industries SdnBhd

Cook South East Asia

Connexall


Schedule 

日程


Event Schedule


Thursday

May 9, 2019


Regulatory & Policy Environment in APAC Jurisdictions


Friday

May 10, 2019

Market Access and Regulatory Compliance

Clinical Trials and New Product Development

Procurement and Allocation

Quality Assurance and Quality Control


For further information, please contact:

Ms. Cindy CUI

Tel: + 86215258 8005 Ext. 8253


广告
游客需要先 登录 才能评论
评论(0)
暂无评论
独家报道
一周审评审核动态内容,一文全通晓。
4小时前 阅读: 1350
无法根治的“干燥综合征”~何时会有根治性药物?
4小时前 阅读: 1199
一周医药圈子里的大事件,一周君带你速揽。
4小时前 阅读: 1277
本周又有4品种过评,2品种审批完毕,13品种申报受理。
3天前 阅读: 3818
市场调研指的是运用科学的手段与方法收集信息。
3天前 阅读: 4025
CDE承办的一致性评价受理号已达1289个,共计373个品种...
3天前 阅读: 4147
一批国内创新药研发明星企业诞生于苏州生物医药产业园。
4天前 阅读: 5014
儿药欠缺,利好政策鼓励发展--儿童用药如何选择立项?
4天前 阅读: 4982
常规的仿制品种多,速度决定一切。
5天前 阅读: 4745
热门推荐
原创新药到底如何才能做出来?
4小时前 阅读: 1111
如何让各项政令口径一致,步调统一?
3天前 阅读: 2007
浙江省重点推行复合式医保支付方式,全面推行总额预算管理,推行...
3天前 阅读: 1809
谋合作,共发展。
4天前 阅读: 2452
药政轮番上台,中国企业登上国际舞台;聚能创新,已成为中国药企...
5天前 阅读: 2002
《中国医药研发40年大数据》,记录了40年来中国医药企业的研...
5天前 阅读: 2092
2019年上半年,国内生物、医药领域共有63起融资事件,总计...
6天前 阅读: 1581
国务院近日印发《国务院关于实施健康中国行动的意见》,国家层面...
6天前 阅读: 1805
近日,美国FDA批准了本年度第8个NME(New Molec...
1星期前 阅读: 1945
新华网专题药智数据企业版药智数据APP迭代版上线药智数据PDI大会专题